Innovation Forum Medizintechnik
Exklusiv für Teilnehmer des iNNOVATION fORUM am 18. Oktober 2017!

Gemeinsam mit den internationalen Teilnehmern unseres 9. Innovation Forum für Medizintechnik möchten wir uns unter dem diesjährigen Leitgedanken „Disruptive Innovationen – welche neuen Wege nimmt die Medizintechnik in der Klinik?“ auf das Forum einstimmen.

Wir laden alle Teilnehmer des Innovation Forums herzlich ein, zusammen mit unseren Gästen der internationalen Delegationen aus den USA, Finnland und den Niederlanden an 9 Thementischen über innovative Themen und Lösungskonzepte aus der gesamten Medizintechnik zu diskutieren. Moderiert werden die Round Tables von Experten aus Wirtschaft und Wissenschaft aus Deutschland und den Niederlanden.

Im Anschluss an die Round Table Diskussionen gibt es ein Get-together zum Networking. Für das leibliche Wohl wird gesorgt sein.


Die Teilnahme am iNNOVATION Warm-up ist für Teilnehmer des iNNOVATION fORUM kostenfrei.
Bitte melden Sie sich bis zum 16. Oktober 2017 an:

Hier geht es zur online-Anmeldung

oder schreiben Sie uns eine E-mail an:

Wir freuen uns auf Ihre Teilnahme!

Round Tables:

Bitte beachten Sie die unten aufgeführten Round Table-Themen. Es wird drei Disskussionsrunden geben, jede dauert 20 Minuten. Bitte wählen Sie für sich drei (3) der unten aufgeführten Themen aus, bei deren Diskussion Sie sich gern beteiligen möchten.

18:00 Uhr


Yvonne Glienke, Vorstand MedicalMountains & Geschäftsführerin TechnnologyMountains

John Blakendaal, Geschäftsführer, Brainport Industries

18:15 Uhr

Thementisch Runde 1

Bitte wählen Sie für sich eines von den unten aufgeführten Themen aus.

18:45 Uhr

Thementisch Runde 2

Bitte wählen Sie für sich eines von den unten aufgeführten Themen aus.

19:15 Uhr

Thementisch Runde 3

Bitte wählen Sie für sich eines von den unten aufgeführten Themen aus.

19:45 Uhr


20:15 – 21:00 Uhr


Table 1: Cleanliness as advantage in competition

Cleaning is often an underestimated, but necessary part in the production process without any creation of value. It is done at the end of the process and should remove all production residues. The question is: How clean is clean enough? To meet the regulatory specification is difficult enough, because there are no regulatory safety values for implants or chirurgical instruments. Soon we discovered that cleaning

  • is part of nearly every step of the production
  • process is a topic for material science, especially surface science
  • can improve your productivity
  • can improve your customer satisfaction
  • is a real advantage in competition

This was the start of the cooperation network CleanMed with MedicalMountains, manufacturers of medical devices manufacturers, cleaning agents, and equipment and research institutes. The network addresses different topics such as standardization, validation, construction with materials and production processes, functional surfaces, activation and cleaning of surfaces, technical cleanliness in machined and forming production processes, particles and cooling lubricant, and cleaning with alternative cleaning methods.

  • Do you agree with our statements?
  • Do we need regulatory safety limits for cleanliness?
  • Is the total amount of carbon sufficient or do we need limits for each substance because of toxicological aspects?
  • Is the topic cleanliness part of each step in your production process?

Moderator: Dr. Dagmar Martin, The Natural and Medical Sciences Institute NMI


Tier-one, tier-two and tier-three suppliers in the open High-Tech supply chain in The Netherlands have joined forces to create Brainport Industries. Brainport Industries designs, develops and manufactures leading, advanced, precise and intelligent high tech equipment.
OEMs competing on the international market for high-mix, low-volume, high-complexity machines have been outsourcing the manufacturing of sub-assemblies and larger non-core submodules to strategic suppliers for quite some time and are now increasingly outsourcing the design and development of the equipment they manufacture as well. What they’re doing in fact, is giving suppliers full responsibility for these modules, from design through to manufacturing.
This shift is driving suppliers to push their own boundaries in terms of feasibility and responsibility, and to extend their reach across international borders in order to tap into new, foreign markets. Let’s discuss!

Moderator: John Blankendaal, Brainport Industries

Digitization will more and more affect the medical technology sector. This round table will therefore focus on Smart Manufacturing in terms of discussing the integration of potential software tools like electronic device history records (eDHR) and manufacturing execution systems (MES) during the development and manufacturing process, respectively. Hahn-Schickard will open the discussion by explaining its strategy of its new to-built micromedical research and transfer foundry MedAssembly, and how potentially interested medical device manufacturers can benefit from it. On the other hand, the discussion will serve to share the experiences of already established systems from participating manufacturers, especially in this strongly regulated environment.

Moderators: Simon Herrlich, Hahn-Schickard Insitute & Marc Holfelder, LA2 GmbH

Nowadays technological innovations are developing more rapidly than ever. Globalization, coverage and speed of the internet, Moore’s Law, 3D printing and the trend towards low volume high complexity systems are some of the drivers that we have to deal with. The question how to deal with these things and the fast changing world? Are you already focusing on new technologies for your business or company? Are you experienced with implementing new technologies like additive manufacturing and Internet-of-Things? Have you identified threats and opportunities?

Moderator: Paul Simons, TSG Group

Innovative technical science and industrial research & development can not be successful without the proper craftsman to realize high level and precise instruments and tools to do practical research with.

We will discuss the future demands for specialized precision craftsmen. What are the necessary standards for future craftsman in the medical precision and instrument market? One of our school’s policy is that these craftsmen should be able to communicate on various levels, such as scientists, engineers and production staff members. Or do we foresee that development will see more and more automatization, such as 3D printers so that design and construction of prototypes is done by merely pushing buttons on CNC-machines etc.

The big question is, if we are not afraid of the risk for loss of knowledge and skills and what we should do in our education system. I’d like to hear opinions and share visions on this subject.

Moderator: Dirck Harms, Leidse instrumentenmakers School

In the context of more and more miniaturized medical instruments or active implants (e.g. the Retina Chip), a need for new technologies addressing the challenge of miniaturization arises in many fields.

  • How can we electrically insulate small metal parts without using thick materials which disturb optical performance (e.g. HF-electrodes in small endoscopes)?
  • What are the next encapsulation-strategies for implantable flexible electronic circuits beyond pace-maker-housings?
  • What are other challenges caused by more sophisticated and miniaturized instruments?

After a short presentation about next generation medical instruments and implants as well as some current approaches for solving the problems, we will discuss the needs of your products and possible options.

If necessary, research proposals for funded projects can be discussed.

Moderator: Prof. Dr. Volker Bucher, Hochschule Furtwangen HFU

In the context of innovation, the following questions arise among many companies:

  • How do we find new technologies to our products?
  • With what offerings can we broaden the range of our services?
  • Who is the right R&D-Partner, for example, for digitalizing our products and services?

We will discuss which approaches and methods as an answer to these questions are suitable and tested, what results are to be achieved, and what organizational measures are necessary to implement them.

A short presentation of the opportunities and risks of digitalization as well as big data applications in the search for technologies is the starting point of our discussion.

Moderator: Univ. Prof. Dr.-Ing. habil. Joachim Warschat, Fraunhofer Institut für Arbeitswirtschaft und Organisation, IAO

New innovations arise through cooperation. This requires both public and private partners in order to facilitate cooperation and accelerate innovation.

In the field of medical devices the Netherlands and Germany have set up structural cooperation leading to new research and innovative products. The Netherlands as an incubator and test field for new innovations. Germany as an economic powerhouse and large producer of medical devices. Two countries with a different innovation approach. However, through their differences mutually beneficial in driving innovation.

Using examples from the Dutch-German cooperation this round table session will discuss what works and what challenges there are in setting up and executing international innovation cooperation.

Moderator: Lars Kramer, MSc., Officer for Innovation, Science & Technology, Consulate General of the Kingdom of the Netherlands in Munich

How would you estimate the trend of personalization requirements in your company such as customer-specific solutions, variants, and standards? How does your innovation system / process also work for other industries?

Companies prepared to stay “fit-for-future”  deal with cross-sectoral challenges in order to bring new personalized products and services in medtech markets. The success factors for innovation will be transferred to the medtech companies by creating networks in the fields of microsystems, life sciences, new materials, and mechatronics.

The starting point for the discussion is: How to develop a cross-sectoral strategy for medtech companies and personalized innovations in order to systematically reach new markets (B2C, B2U) outside the regulated medtech market?

For example, best-practice methods enable medtech companies to adopt their innovation process to personalized products and solutions outside the medtech market. The successful best-practice examples of the participating companies happen as part of the different involved networks.

This will enable the medtech companies to create a higher growth with good profit by using the potential of the business-to-user (B2U) strategy. Key elements are the enlargement of the innovation system by a human centered design approach in combination with an agile innovation process approach using the possibilites of digitalization and corresponding new business innovation models.

Moderator: Günther Würtz, Steinbeis Innovationszentrum Innovation Engineering